Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,398,398
+$466,851 QoQ
Shares Held
13,505
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.18%
of 13F equity value
Holder Rank
#1,563
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EXCALIBUR MANAGEMENT CORP holds $32,863,371 across 10 Drug Manufacturers - General names. ABBV ranks #4 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
37,287 | $9,469,779 | |
| 2 | MRK |
Merck & Co., Inc.
|
52,387 | $6,731,729 | |
| 3 | PFE |
Pfizer Inc
|
155,777 | $3,751,110 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
13,505 | $3,398,398 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
21,349 | $2,697,232 | |
| 6 | AMGN |
Amgen Inc
|
6,407 | $2,320,102 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
34,161 | $1,968,356 | |
| 8 | LLY |
ELI LILLY & Co
|
1,361 | $1,632,424 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,398,398 | 13,505 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,931,547 | 13,479 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $3,072,962 | 13,449 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,177,886 | 13,725 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,543,179 | 13,701 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $2,877,966 | 13,736 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,444,263 | 13,755 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,735,492 | 13,852 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,411,056 | 14,057 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,531,554 | 13,902 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,169,425 | 13,999 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,087,585 | 14,005 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,861,025 | 13,813 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,190,859 | 13,747 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $2,243,308 | 13,881 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,875,853 | 13,977 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $2,136,888 | 13,952 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $2,619,211 | 16,157 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $2,079,879 | 15,361 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,624,414 | 15,059 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,684,756 | 14,957 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,629,468 | 15,057 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $1,523,565 | 14,219 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $900,250 | 10,278 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $1,005,166 | 10,238 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $690,586 | 9,064 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||